Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies

MLA

Alessandra Aiello, et al. “Longitudinal Characterisation of B and T-Cell Immune Responses after the Booster Dose of COVID-19 MRNA-Vaccine in People with Multiple Sclerosis Using Different Disease-Modifying Therapies.” Journal of Neurology, Neurosurgery, and Psychiatry, Aug. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....40612d02cf1cea500071f55158403e42&authtype=sso&custid=ns315887.

APA

Alessandra Aiello, Andrea Coppola, Serena Ruggieri, Chiara Farroni, Anna Maria Gerarda Altera, Andrea Salmi, Valentina Vanini, Gilda Cuzzi, Linda Petrone, Silvia Meschi, Daniele Lapa, Aurora Bettini, Shalom Haggiag, Luca Prosperini, Simonetta Galgani, Maria Esmeralda Quartuccio, Nazario Bevilacqua, Anna Rosa Garbuglia, Chiara Agrati, … Delia Goletti. (2022). Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies. Journal of Neurology, Neurosurgery, and Psychiatry.

Chicago

Alessandra Aiello, Andrea Coppola, Serena Ruggieri, Chiara Farroni, Anna Maria Gerarda Altera, Andrea Salmi, Valentina Vanini, et al. 2022. “Longitudinal Characterisation of B and T-Cell Immune Responses after the Booster Dose of COVID-19 MRNA-Vaccine in People with Multiple Sclerosis Using Different Disease-Modifying Therapies.” Journal of Neurology, Neurosurgery, and Psychiatry, August. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....40612d02cf1cea500071f55158403e42&authtype=sso&custid=ns315887.